Biodyne Past Earnings Performance
Past criteria checks 0/6
Biodyne has been growing earnings at an average annual rate of 53%, while the Medical Equipment industry saw earnings growing at 17.7% annually. Revenues have been growing at an average rate of 18% per year.
Key information
53.0%
Earnings growth rate
62.5%
EPS growth rate
| Medical Equipment Industry Growth | 22.7% |
| Revenue growth rate | 18.0% |
| Return on equity | -2.1% |
| Net Margin | -21.3% |
| Last Earnings Update | 30 Jun 2024 |
Revenue & Expenses Breakdown
How Biodyne makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 4,196 | -893 | 2,164 | 291 |
| 31 Mar 24 | 4,076 | -1,332 | 2,026 | 348 |
| 31 Dec 23 | 4,089 | -992 | 1,832 | 383 |
| 30 Sep 23 | 11,787 | 4,869 | 1,752 | 431 |
| 30 Jun 23 | 12,064 | 5,477 | 1,743 | 428 |
| 31 Mar 23 | 11,926 | 5,832 | 1,675 | 422 |
| 31 Dec 22 | 12,210 | 5,611 | 1,819 | 412 |
| 30 Sep 22 | 5,204 | -200 | 1,930 | 353 |
| 30 Jun 22 | 4,567 | -995 | 1,929 | 359 |
| 31 Mar 22 | 4,506 | -1,160 | 1,924 | 383 |
| 31 Dec 21 | 3,763 | -10,857 | 2,159 | 391 |
| 30 Sep 21 | 3,301 | -12,771 | 1,989 | 472 |
| 30 Jun 21 | 3,375 | -13,439 | 1,849 | 463 |
| 31 Mar 21 | 3,380 | -13,772 | 1,847 | 451 |
| 31 Dec 20 | 3,671 | -4,454 | 1,589 | 445 |
| 30 Sep 20 | 4,273 | -4,302 | 2,378 | 667 |
| 31 Dec 19 | 4,089 | -2,026 | 2,082 | 534 |
| 31 Dec 18 | 3,771 | -1,380 | 1,180 | 181 |
| 31 Dec 17 | 4,697 | 513 | 1,346 | 158 |
| 31 Dec 15 | 3,609 | -157 | 1,363 | 189 |
| 31 Dec 14 | 3,024 | -97 | 1,034 | 305 |
Quality Earnings: A314930 is currently unprofitable.
Growing Profit Margin: A314930 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A314930 is unprofitable, but has reduced losses over the past 5 years at a rate of 53% per year.
Accelerating Growth: Unable to compare A314930's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A314930 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (7.6%).
Return on Equity
High ROE: A314930 has a negative Return on Equity (-2.07%), as it is currently unprofitable.